mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.6 |